| Next 10 |
Ad
OCGN News and Press Ocugen Inc.
News | Ocugen, Inc. (NASDAQ:OCGN)
-
2025-03-05 13:15:17 ET Image source: The Motley Fool. Ocugen (NASDAQ: OCGN) Q4 2024 Earnings Call Mar 05, 2025 , 8:30 a.m. ET Operator Continue reading
-
2025-03-05 10:59:18 ET Ocugen, Inc. (OCGN) Q4 2024 Earnings Conference Call March 05, 2025, 08:30 AM ET Company Participants Tiffany Hamilton - Head, Corporate Communications Shankar Musunuri - Chairman, Chief Executive Officer & Co-Founder Ramesh Ramachandra...
-
2025-03-05 07:08:40 ET More on Ocugen Ocugen Q4 2024 Earnings Preview Ocugen aligns with FDA on confirmatory study for OCU410ST Seeking Alpha’s Quant Rating on Ocugen Historical earnings data for Ocugen Financial information for Ocugen ...
-
Kodiak Gas Services Inc. (KGS) is expected to report $0.26 for Q4 2024 Kronos Worldwide Inc (KRO) is expected to report $0.11 for Q4 2024 Neonode Inc. (NEON) is expected to report for Q4 2024 Applied Therapeutics Inc. (APLT) is expected to report $-0.18 for Q4 2024 Churchill Capit...
-
2025-03-04 10:33:35 ET More on Ocugen Ocugen aligns with FDA on confirmatory study for OCU410ST Ocugen gets positive EU opinion for ATMP classification for OCU400 Seeking Alpha’s Quant Rating on Ocugen Historical earnings data for Ocugen Financ...
-
2025-03-02 08:00:41 ET As Wall Street steps into March, the earnings schedule offers a look at how a broad range of industries are navigating the current economic landscape.... Read the full article on Seeking Alpha For further details see: Earnings week ahead: TGT, COST, CR...
-
2025-02-28 15:00:04 ET More on the markets Get Your Shopping List Ready, Possible Epic Time To Buy VFLO: A More Defensive ETF To Navigate Slower S&P 500 Growth The Mistake Of Looking For Tops In The Stock Market South Korea and U.S. finance chief discuss ...
-
2025-02-27 09:54:05 ET More on Ocugen Ocugen gets positive EU opinion for ATMP classification for OCU400 Seeking Alpha’s Quant Rating on Ocugen Historical earnings data for Ocugen Financial information for Ocugen Read the full article on Seek...
-
2025-02-05 18:28:30 ET Summary Today, we look at Belite Bio, Inc., a clinical-stage biotech company that is focusing on developing novel therapeutics for retinal degenerative eye diseases. The company's primary pipeline asset is in late-stage development for two indications that h...
-
2025-02-03 12:25:17 ET More on Ocugen Ocugen, Inc. (OCGN) Q3 2024 Earnings Call Transcript Ocugen reports positive data for OCU400, OCU410 Ocugen Q3 2024 Earnings Preview Seeking Alpha’s Quant Rating on Ocugen Historical earnings data for Ocuge...
Stock Information
Get OCGN Alerts
News, Short Squeeze, Breakout and More Instantly...
Ocugen, Inc. Company Name:
OCGN Stock Symbol:
NASDAQ Market:
2.2% G/L:
$0.5163 Last:
6,662,829 Volume:
$0.56 Open:
$0.5163 Close:
Ocugen, Inc. Website:
Ad
-
2025-03-05 13:15:17 ET Image source: The Motley Fool. Ocugen (NASDAQ: OCGN) Q4 2024 Earnings Call Mar 05, 2025 , 8:30 a.m. ET Operator Continue reading
-
Kodiak Gas Services Inc. (KGS) is expected to report $0.26 for Q4 2024 Kronos Worldwide Inc (KRO) is expected to report $0.11 for Q4 2024 Neonode Inc. (NEON) is expected to report for Q4 2024 Applied Therapeutics Inc. (APLT) is expected to report $-0.18 for Q4 2024 Churchill Capit...
-
100% (9/9) of treated evaluable subjects demonstrated improvement or preservation in visual function compared to untreated eyes at both one and two years 100% (9/9) of treated evaluable subjects demonstrated improvement or stabilization in mobility testing, which was only performed up to one ...